Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Rosa Ingrosso
Observed name:
M.R. Ingrosso
Institution:
University of Rome Tor Vergata
Observed institutions:
Università Cattolica del Sacro Cuore,
University of Rome Tor Vergata,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-5919-2922
Observed ORCID:
0000-0001-5919-2922
OpenAlex ID:
A5014582818
Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome
2022
·
Maria Rosa Ingrosso
, Gianluca Ianiro
, et al.
·
Alimentary Pharmacology & Therapeutics
·
72
Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis
2024
·
Serena Porcari
, Maria Rosa Ingrosso
, et al.
·
Gut
·
60
PDF
Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis
2022
·
Maria Rosa Ingrosso
, Michael Camilleri
, et al.
·
Gastroenterology
·
59
PDF
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis
2023
·
Serena Porcari
, Simon Mark Dahl Baunwall
, et al.
·
Journal of Autoimmunity
·
47
PDF
Response and Adverse Event Rates With Placebo in Gastroparesis: A Systematic Review and Meta-analysis
2022
·
Journey L. Wise
, Maria Rosa Ingrosso
, et al.
·
Clinical Gastroenterology and Hepatology
·
11
PDF
AVT04, a Biosimilar to Reference Product Ustekinumab, for the Treatment of Plaque Psoriasis: Insights from a Real-World Experience up to 28 Weeks
2026
·
Edoardo Mortato
, Marina Talamonti
, et al.
·
Dermatology and Therapy
·
1
PDF
Letter: The multifaceted role of Escherichia coli in influencing disorders of industrial populations
2024
·
Maria Rosa Ingrosso
, Antonio Gasbarrini
, et al.
·
Alimentary Pharmacology & Therapeutics
·
1
PDF
Oc.02.5: Metabolic Disorders in Coeliac Disease After Glutenfree Diet
2024
·
S. Bibbò
, A. Del Gaudio
, et al.
·
Digestive and Liver Disease
T.06.3: Prevalence Of, and Microbial Risk Factors For, Irritable Bowel Syndrome and Functional Dyspepsia After Acute Gastrointestinal Infection: a Systematic Review and Meta-analysis
2024
·
S. Porcari
, M.R. Ingrosso
, et al.
·
Digestive and Liver Disease
T.06.8: a Microbiome Testing-based Precision Medicine Approach to Treat Post-infectious Irritable Bowel Syndrome: a Pilot Study
2024
·
W. Fusco
, E. Tohumcu
, et al.
·
Digestive and Liver Disease
Oc.04.6: Screening of Donor Feces With a Direct Stool Testingbased Approach: Framework and Outcomes of a Largevolume Donor Stool Biobank for Fecal Microbiota Transplantation
2024
·
D. Rondinella
, G. Quaranta
, et al.
·
Digestive and Liver Disease
Boc.02.1: Efficacy and Safety of Fecal Microbiota Transplantation for the Treatment of Clostridioides Difficile Infection: a 10-year Experience of a Largevolume Fmt Center
2024
·
G. Ianiro
, L. Masucci
, et al.
·
Digestive and Liver Disease
T.11.4: Targeting the Intestinal Ecosystem Through a Gut Microbiome Testing to Treat Recurrent Urinary-tract Infections From Gut Pathobionts: a Pilot Study
2024
·
T. Rozera
, E. Tohumcu
, et al.
·
Digestive and Liver Disease
Reply
2023
·
Maria Rosa Ingrosso
, Christopher J. Black
, et al.
·
Gastroenterology
PDF
T.05.9 Reduced Perception of Well-being, and Higher Level of Anxiety and Depression Distinguish Patients With Noncoeliac Gluten Sensitivity Compared With Celiacs
2023
·
S. Bibbo
, D. Ferrarese
, et al.
·
Digestive and Liver Disease
Letter: efficacy of peppermint oil in irritable bowel syndrome—authors' reply
2022
·
Maria Rosa Ingrosso
, Gianluca Ianiro
, et al.
·
Alimentary Pharmacology & Therapeutics
Show more works
View as search
Works count:
16
Citation count:
251
H-index:
5
I10-index:
5
Year
Topic
Type